Phenotyping the Prediabetic Population-A Closer Look at Intermediate Glucose Status and Cardiovascular Disease
Elena Barbu1, Mihaela-Roxana Popescu1, Andreea-Catarina Popescu1
1Department of Cardiology, Elias Emergency University Hospital, Carol Davila University of Medicine and Pharmacy, 011461 Bucharest, Romania.
Insights
Prediabetes characterization remains controversial despite updated thresholds. Identifying high-risk individuals for cardiovascular disease and closer monitoring is crucial for effective prevention and management.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Cardiovascular Disease
Background:
- The definition of prediabetes lacks precise characterization, despite its known risks for diabetes and vascular complications.
- The current rigid definition overlooks pathophysiological mechanisms and progression towards overt diabetes.
- Inflammation is a common factor in risk factors associated with prediabetes, worsening prognosis.
Purpose of the Study:
- To review screening criteria for prediabetes.
- To identify prediabetic patients at higher risk for cardiovascular disease (CVD).
- To emphasize the need for closer monitoring in high-risk prediabetic individuals.
Main Methods:
- Literature review focusing on prediabetes definition and risk stratification.
- Analysis of pathophysiological mechanisms linking prediabetes to CVD.
- Identification of inflammatory markers and risk factors.
Main Results:
- The prediabetic population is heterogeneous, necessitating refined phenotyping for risk assessment.
- Current definitions do not adequately capture the spectrum of metabolic dysfunction.
- Inflammation is a key driver of CVD risk in prediabetes.
Conclusions:
- Refined phenotyping of prediabetes is essential for personalized risk assessment and prevention strategies.
- Targeted screening and closer monitoring are required for prediabetic individuals at high CVD risk.
- Understanding the role of inflammation is critical for managing prediabetes and preventing complications.
Abstract:
Even though the new thresholds for defining prediabetes have been around for more than ten years, there is still controversy surrounding the precise characterization of this intermediate glucose metabolism status. The risk of developing diabetes and macro and microvascular disease linked to prediabetes is well known. Still, the prediabetic population is far from being homogenous, and phenotyping it into less heterogeneous groups might prove useful for long-term risk assessment, follow-up, and primary prevention. Unfortunately, the current definition of prediabetes is quite rigid and disregards the underlying pathophysiologic mechanisms and their potential metabolic progression towards overt disease. In addition, prediabetes is commonly associated with a cluster of risk factors that worsen the prognosis. These risk factors all revolve around a common denominator: inflammation. This review focuses on identifying the population that needs to be screened for prediabetes and the already declared prediabetic patients who are at a higher risk of cardiovascular disease and require closer monitoring.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
